INFLAMMATORY BIOMARKERS IN CLINICAL PRACTICE: FROM ANTENATAL MONITORING TO PERSONALISED MEDICINE
Authors:
Open Access
- 4 November 2025
- journal article
- Published by Poltava State Medical University (PSMU) in Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії
- Vol. 25 (3) , 267-273
Abstract
Introduction. Proinflammatory biomarkers are universal indicators of pathological processes that provide an interdisciplinary link between obstetrics and paediatrics. Objective: To systematize pro-inflammatory biomarkers with diagnostic, prognostic, and therapeutic value in order to ensure continuity of clinical decision-making in obstetrics and paediatrics, and to support the development of personalized medicine. Materials and Methods. A systematic analysis of the literature was conducted using the PubMed, Scopus, and Web of Science databases. The review focused on data concerning inflammatory biomarkers, their gene polymorphisms, and the evaluation of pharmacotherapeutic effects in obstetrics and paediatrics. Results. Pre-eclampsia is accompanied by an increase in IL-6, TNF-α, CRP, PCT and a decrease in IL-10, which correlates with the severity of endothelial dysfunction, placental inflammation and severity. An increased M1/M2 macrophage ratio is associated with placental infiltration and insufficient trophoblast implantation. Among the polymorphisms associated with pre-eclampsia, the following were found: IL6 -174G>C, TNFA -308G>A, IL10 -1082A>G, which affect the level of cytokine expression and the risk of complications. In neonatal sepsis, PCT, IL-6, TNF-α and CRP increase, while IL-10 decreases. The genetic variants IL6-572G>C, TLR4 Asp299Gly, TNFA-238G>A, IL10-819C>T are associated with an increased risk of neonatal sepsis, severe course and adverse outcomes. The ratio of M1/M2 macrophages in the blood correlates with persistent inflammation and unfavourable prognosis. TNFA -308G>A and IL6 -174G>C polymorphisms affect children's response to glucocorticoids and nonsteroidal anti-inflammatory drugs. Carriers of the IL10 -1082A>G variant have reduced efficacy of immunomodulatory therapy. Conclusions. A systematic approach to the monitoring of inflammatory biomarkers from the antenatal stage to pharmacotherapy in childhood opens up new opportunities for personalised medicine.Keywords
This publication has 33 references indexed in Scilit:
- Transcript-dependent effects of the CALCA gene on the progression of post-traumatic osteoarthritis in miceCommunications Biology, 2024
- An analysis of COVID-19 vaccination campaign in UkraineEuropean Journal of Public Health, 2023
- Pharmacological blockade of the interleukin-1 receptor suppressed Escherichia coli lipopolysaccharide-induced neuroinflammation in preterm fetal sheepAmerican Journal of Obstetrics & Gynecology MFM, 2023
- Selecting analytical biomarkers for diagnostic applications: a first principles approachExpert Review of Molecular Diagnostics, 2017
- The role of inflammation in the pathology of preeclampsiaClinical Science, 2016
- Association Between CRP Gene Polymorphisms and the Risk of Preeclampsia in Han Chinese WomenGenetic Testing and Molecular Biomarkers, 2014
- Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restrictionJournal of Reproductive Immunology, 2003
- Pilot Study Assessing TNF Gene Polymorphism as a Prognostic Marker for Disease Progression in Neonates with SepsisInfection, 2000
- Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic OptionsThe Journal of Infectious Diseases, 2000
- Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to diseaseJournal of Leukocyte Biology, 1999